Published in J Neuroimmunol on October 01, 2002
The role of inflammation in CNS injury and disease. Br J Pharmacol (2006) 3.96
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol (2011) 2.55
Molecular MRI enables early and sensitive detection of brain metastases. Proc Natl Acad Sci U S A (2012) 1.10
alpha4-Integrin antagonism with natalizumab: effects and adverse effects. J Neurol (2008) 0.90
Anti-integrin therapy for multiple sclerosis. Autoimmune Dis (2012) 0.84
Developing therapeutics for the treatment of multiple sclerosis. NeuroRx (2005) 0.83
Adhesion molecules in CNS disorders: biomarker and therapeutic targets. CNS Neurol Disord Drug Targets (2013) 0.75
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
Cloning of a lymphocyte homing receptor reveals a lectin domain. Cell (1989) 3.33
A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature (2001) 3.28
A new class of angiotensin-converting enzyme inhibitors. Nature (1980) 3.03
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet (2001) 2.76
Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation (1995) 2.24
Receptors involved in lymphocyte homing: relationship between a carbohydrate-binding receptor and the MEL-14 antigen. J Cell Biol (1987) 2.13
Involvement of sialic acid on endothelial cells in organ-specific lymphocyte recirculation. Science (1985) 1.85
Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation (2000) 1.70
A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J (1990) 1.67
Are dihydropyridine binding sites voltage sensitive calcium channels? Life Sci (1984) 1.66
Phosphomannosyl-derivatized beads detect a receptor involved in lymphocyte homing. J Cell Biol (1987) 1.64
Relation between ischemia time, infarct size, and left ventricular function in humans. Circulation (1995) 1.57
Calcium channel activation: a different type of drug action. Proc Natl Acad Sci U S A (1984) 1.52
Homing receptors on human and rodent lymphocytes--evidence for a conserved carbohydrate-binding specificity. Blood (1987) 1.51
Impact of medical consultation frequency on modifiable risk factors and medications at 12 months after acute coronary syndrome in the CHOICE randomised controlled trial. Int J Cardiol (2010) 1.50
Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol (1991) 1.45
3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J Med Chem (1996) 1.44
Usefulness of laboratory mental stress test in patients with stable coronary artery disease. Clin Cardiol (1997) 1.43
Verapamil kinetics in normal subjects and patients with coronary artery spasm. Clin Pharmacol Ther (1981) 1.43
Interaction of aluminum species with deoxyribonucleic acid. Biochemistry (1980) 1.39
GlyCAM-1, a physiologic ligand for L-selectin, activates beta 2 integrins on naive peripheral lymphocytes. J Exp Med (1996) 1.39
Significance of precordial T-wave inversion in inferior wall acute myocardial infarction. Am J Cardiol (1995) 1.39
Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging (2000) 1.37
Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J Biol Chem (1995) 1.33
Tetrahydropyridyloxadiazoles: semirigid muscarinic ligands. J Med Chem (1991) 1.29
Identification and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines. J Neurosci (1984) 1.24
Intravenously injected sialidase inactivates attachment sites for lymphocytes on high endothelial venules. J Immunol (1989) 1.21
A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol (1995) 1.20
Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. Am J Cardiol (1982) 1.17
Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors. J Med Chem (1990) 1.16
VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J Neuroimmunol (2009) 1.15
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. Int J Cardiol (2010) 1.11
Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J Immunol (1997) 1.10
Regulation of conformation and ligand binding function of integrin alpha5beta1 by the beta1 cytoplasmic domain. J Biol Chem (1996) 1.08
A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion. J Biol Chem (1998) 1.06
Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease. Intern Med J (2005) 1.00
Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis. Hum Antibodies (1997) 1.00
Influence of coronary collateral blood flow on the development of exertional ischemia and Q wave infarction in patients with severe single-vessel disease. Circulation (1985) 0.99
Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol (1992) 0.99
VEGF and vascular changes in chronic neuroinflammation. J Autoimmun (2003) 0.98
Endothelial selectins and alpha4 integrins regulate independent pathways of T lymphocyte recruitment in the pulmonary immune response. J Immunol (1998) 0.96
Influence of sodium and sulphydryl groups on [3H]sulpiride binding sites in rat striatal membranes. J Neurochem (1982) 0.94
Functional expression of human D3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells. Br J Pharmacol (1994) 0.93
Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer. J Urol (1996) 0.93
Phosphorus-containing inhibitors of angiotensin-converting enzyme. Proc Natl Acad Sci U S A (1982) 0.93
Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. J Magn Reson Imaging (1994) 0.92
Binding of [3H]sulpiride to purified rat striatal synaptic membranes. Neuroscience (1981) 0.92
The effects of dihydropyridines on neurotransmitter release from cultured neuronal cells. Life Sci (1984) 0.91
Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells. FEBS Lett (1993) 0.91
Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells. FEBS Lett (1992) 0.90
Four-year follow-up of the Choice of Health Options In prevention of Cardiovascular Events randomized controlled trial. Eur J Cardiovasc Prev Rehabil (2011) 0.90
Specific receptor-mediated inhibition of cyclic AMP synthesis by dopamine in a neuroblastoma X brain hybrid cell line NCB-20. J Neurochem (1984) 0.89
High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group. J Med Chem (1994) 0.88
[3H]Sulpiride, a ligand for neuroleptic receptors. Neuropharmacology (1981) 0.88
Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. J Med Chem (1990) 0.88
In vivo treatment with anti-alpha4 integrin suppresses clinical and pathological evidence of Borna disease virus infection. J Neuroimmunol (1998) 0.87
Computational blood flow modeling based on in vivo measurements. Ann Biomed Eng (1999) 0.87
5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors. J Med Chem (1996) 0.86
Differential regulation of beta1 integrins by chemoattractants regulates neutrophil migration through fibrin. J Cell Biol (1999) 0.86
Differentiation of parenchymal lung disorders with in vitro proton nuclear magnetic resonance. Magn Reson Med (1986) 0.85
Interactions of maitotoxin with voltage-sensitive calcium channels in cultured neuronal cells. Proc Natl Acad Sci U S A (1984) 0.85
Prediction of multivessel coronary artery disease and prognosis early after acute myocardial infarction by exercise electrocardiography and thallium-201 myocardial perfusion scanning. Am J Cardiol (1986) 0.84
NMR studies in experimental allergic encephalomyelitis (EAE): normalization of T1 and T2 with parenchymal cellular infiltration. Neurology (1986) 0.84
Connexin 43 gap junction proteins are up-regulated in remyelinating spinal cord. J Neurosci Res (2007) 0.84
Ergonovine-induced myocardial ischemia: no role for serotonergic receptors? Circulation (1984) 0.84
Pharmacology of high-threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors. Br J Pharmacol (1994) 0.84
An open-trial evaluation of mitoxantrone in the treatment of progressive MS. Neurology (1993) 0.84
Depression of high-threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108-15 cells. Br J Pharmacol (1994) 0.84
Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation. Eur J Pharmacol (1994) 0.83
Many major CNS axon projections develop normally in the absence of semaphorin III. Mol Cell Neurosci (1998) 0.83
Clinical studies of patients with coronary spasm. Am J Cardiol (1983) 0.82
Expression and functional significance of an activation-dependent epitope of the beta 1 integrins in chronic inflammatory diseases. Eur J Immunol (1995) 0.82
Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina. Eur Heart J (1992) 0.82
NMR changes in experimental allergic encephalomyelitis: NMR changes precede clinical and pathological events. Magn Reson Med (1987) 0.82
The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion. Am J Cardiol (1991) 0.82
C-reactive protein contributes to the hypercoagulable state in coronary artery disease. J Thromb Haemost (2006) 0.82
Modular prevention of heart disease following acute coronary syndrome (ACS) [ISRCTN42984084]. BMC Cardiovasc Disord (2006) 0.81
The potassium channel activator, BRL 34915, antagonises a behavioural response to the muscarinic receptor agonist, pilocarpine. Eur J Pharmacol (1988) 0.81
In vivo measurements of multi-component T2 relaxation behaviour in guinea pig brain. Magn Reson Imaging (1999) 0.81
Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations. J Med Chem (1986) 0.81
Experimental allergic encephalomyelitis in connexin 43-heterozygous mice. Cell Commun Adhes (2007) 0.81
Benzolactams. A new class of converting enzyme inhibitors. Biochem Biophys Res Commun (1983) 0.81
An extension of the f-fragment method for the calculation of hydrophobic constants (log P) of conformationally defined systems. J Med Chem (1983) 0.81
A study on the localization of [3H]sulpiride binding sites in rat striatal membranes. Neuropharmacology (1981) 0.80
L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. J Pharmacol Exp Ther (1997) 0.80
Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: comparison of functional magnetic resonance imaging and visual evoked potentials. Mult Scler (1999) 0.80
Mechanism and significance of precordial ST-segment depression during inferior wall acute myocardial infarction associated with severe narrowing of the dominant right coronary artery. Am J Cardiol (1993) 0.80
Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. Thromb Res (2008) 0.79
Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor. Mol Pharmacol (1996) 0.79
Implications of ST changes in reperfusion management of acute inferior myocardial infarction. Eur Heart J (1994) 0.79
Correlation between post-ejection shortening and improvement in regional wall motion after revascularization in patients with coronary artery disease. Int J Cardiol (1996) 0.79
Producing picture-perfect posters. AJR Am J Roentgenol (1993) 0.79
Biochemical measurement of muscarinic receptor efficacy and its role in receptor regulation. Trends Pharmacol Sci (1988) 0.79
Coronary artery spasm: use of ergonovine in diagnosis. Aust N Z J Med (1980) 0.78
Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris. Am J Cardiol (1989) 0.78